← FDA DRUG APPROVALS

FDA ANDA · ANDA074536

HALOPERIDOL LACTATE

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA074536
TYPE
ANDA
ORIGINAL APPROVAL
1995-11-02
LATEST ACTION
2017-02-23
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

HALOPERIDOL LACTATEDiscontinued
HALOPERIDOL LACTATE EQ 1MG BASE/ML · SOLUTION · ORAL

Approval history

2017-02-23Labeling · Supplement 2 · standardAP
2015-11-04Labeling · Supplement 1AP
1995-11-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →